SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
DASEKE DON R

(Last) (First) (Middle)
15455 DALLAS PARKWAY #440

(Street)
ADDISON TX 75001

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Daseke, Inc. [ DSKE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
CEO and President
3. Date of Earliest Transaction (Month/Day/Year)
02/27/2017
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/27/2017 A 1,308,795 A (1) 1,308,795 D
Common Stock 02/27/2017 A 13,757,629 A (1) 13,757,629 I By The Walden Group, Inc.(2)
Common Stock 02/27/2017 A 28,841 A (1) 28,841 I By spouse(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) $9.98 02/27/2017 A 130,000 (4) 02/27/2027 Common Stock 130,000 $0 130,000 D
1. Name and Address of Reporting Person*
DASEKE DON R

(Last) (First) (Middle)
15455 DALLAS PARKWAY #440

(Street)
ADDISON TX 75001

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
X Officer (give title below) Other (specify below)
CEO and President
1. Name and Address of Reporting Person*
Walden Group, Inc.

(Last) (First) (Middle)
15455 DALLAS PARKWAY #440

(Street)
ADDISON TX 75001

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. Received pursuant to the Agreement and Plan of Merger, dated December 22, 2016 (the "Merger Agreement"), among the issuer, Daseke Companies, Inc. (f/k/a Daseke, Inc. and referred to herein as "Old Daseke"), a wholly owned subsidiary of the issuer and the Stockholder Representative (as defined therein). At the Effective Time (as defined in the Merger Agreement), each share of Old Daseke common stock issued and outstanding immediately prior to the Effective Time was automatically converted into the right to receive 144.204 shares of the issuer's common stock (rounded to the nearest whole share), upon the terms and subject to the conditions set forth in the Merger Agreement. The closing price of the issuer's common stock was $10.22 per share on the effective date of the merger.
2. Held of record by The Walden Group, Inc. Mr. Daseke is the President and majority stockholder of The Walden Group, Inc. and therefore may be deemed to beneficially own all of the shares held of record thereby; however, Mr. Daseke disclaims beneficial ownership of the shares held of record by The Walden Group, Inc. except to the extent of his pecuniary interest therein.
3. Held of record by Mr. Daseke's spouse. Mr. Daseke may be deemed to beneficially own all of the shares held of record by his spouse; however, Mr. Daseke disclaims beneficial ownership of the shares held of record by his spouse except to the extent of his pecuniary interest therein.
4. The option vests in five equal annual installments beginning on February 27, 2018.
/s/ Don R. Daseke 03/01/2017
/s/ Don R. Daseke, President of The Walden Group, Inc. 03/01/2017
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.